Latest Island Pharmaceuticals (ASX:ILA) News
Page 4
Page 4 of 6
Island Pharmaceuticals Expands Pipeline with Galidesivir Amid Rising Losses
25 Feb 2026
Healthcare Wrap - Week 7 (9 Feb -> 13 Feb) 2026
14 Feb 2026
Island Pharmaceuticals Clarifies FDA Feedback Impact and $9m Capital Raise
10 Feb 2026
Market Wrap - Week 6 (2 Feb -> 6 Feb) 2026
7 Feb 2026
Healthcare Wrap - Week 6 (2 Feb -> 6 Feb) 2026
7 Feb 2026
Island Pharmaceuticals Secures $9M to Propel Galidesivir Toward FDA Approval
4 Feb 2026
FDA Greenlights Galidesivir’s Animal Rule Pathway, Paving Way for Accelerated Approval
4 Feb 2026
Healthcare Wrap - Week 5 (26 Jan -> 30 Jan) 2026
31 Jan 2026
Island Pharmaceuticals Advances Galidesivir with FDA Backing and US Partnerships
27 Jan 2026
Island Pharmaceuticals Secures US Patent for Galidesivir to Combat Deadly Filoviruses
7 Jan 2026
Island Pharmaceuticals Advances Galidesivir Amid FDA Review Delay
5 Jan 2026
Island Pharmaceuticals Secures Texas Biomed Pact to Propel Galidesivir FDA Pathway
17 Dec 2025